auroushealthcare.wordpress.com
SEC recommends approval for Astrazeneca’s anti-hyperkalaemia drug Lokelma in India
The Subject Expert Committee (SEC) which advises the national drug regulator on drug approvals and clinical trials has recommended grant of permission to drug major Astrazeneca for import and marke…
